Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 15 July 2003
Vol. 2003, Issue 191, p. re12
[DOI: 10.1126/stke.2003.191.re12]

REVIEWS

SH2 and PTB Domains in Tyrosine Kinase Signaling

Joseph Schlessinger1* and Mark A. Lemmon2

1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
2Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Abstract: Intracellular signaling pathways that involve protein tyrosine kinases (PTKs) are critical for the control of most cellular processes. Dysfunctions in PTKs, or in the signaling pathways that they regulate, result in a variety of diseases such as cancer, diabetes, immune deficiency, and many others. SH2 (Src homology region 2) and PTB (phosphotyrosine-binding) domains are small protein modules that mediate protein-protein interactions involved in many signal transduction pathways. Both domains were initially identified as modules that recognize phosphorylated tyrosines in receptor tyrosine kinases and other signaling proteins. Subsequent studies have shown that, while binding of SH2 domains to their target proteins is strictly regulated by tyrosine phosphorylation, most PTB domains actually bind to their (nonphosphorylated) targets constitutively. The functions of SH2 and PTB domains include targeting of their host proteins to different cellular compartments, assembly of key components of signaling pathways in response to extracellular signals, and the control of autoinhibition, activation and dimerization of their host proteins. The information flow from the cell surface to different cellular compartments to regulate the cell cycle, cell shape and movement, cell proliferation, differentiation and cell survival are all controlled in part by SH2 and PTB domains that can recognize phosphotyrosine or particular amino acid sequence motifs in a wide variety of target molecules.

*Corresponding author. Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, SHM B-204, New Haven, CT 06520, USA. Telephone, (203) 785-7395; e-mail, joseph.schlessinger{at}yale.edu

Citation: J. Schlessinger, M. A. Lemmon, SH2 and PTB Domains in Tyrosine Kinase Signaling. Sci. STKE 2003, re12 (2003).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Combinatorial ShcA Docking Interactions Support Diversity in Tissue Morphogenesis.
W. R. Hardy, L. Li, Z. Wang, J. Sedy, J. Fawcett, E. Frank, J. Kucera, and T. Pawson (2007)
Science 317, 251-256
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882